Recently, a novel fluidic-based DPV ELISA platform for estimating the protein markers of bladder cancer (nuclear mitotic apparatus protein 1 (NUMA1) and complement factor H-related 1 (CFHR1)) was proposed [110]. This evidence concerns the gene NUMA1 and urinary bladder cancer.